Johnson & Johnson: How Does Darzalex Compare To Other Multiple Myeloma Drugs?

Johnson amp Johnson s 160 JNJ oncology drug Darzalex has been doing well of late and it was recently approved by the U S FDA in combination with Lenalidomide and Dexamethasone for newly diagnosed multiple myeloma patients who are transplant ineligible In this analysis we